These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 11841442

  • 1. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V, Parquet A, Tahiri C, Claeyssens S, Potard V, Faradji A, Peynet J, Costagliola D, Suivi Thérapeutique National des Hémophiles Group.
    Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
    [Abstract] [Full Text] [Related]

  • 2. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.
    Soucie JM, Siwak EB, Hooper WC, Evatt BL, Hollinger FB, Universal Data Collection Project Working Group.
    Transfusion; 2004 Aug; 44(8):1179-85. PubMed ID: 15265122
    [Abstract] [Full Text] [Related]

  • 3. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
    Laurian Y, Dussaix E, Parquet A, Chalvon-Demersay A, d'Oiron R, Tchernia G.
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa.
    Rubinstein R, Karabus CD, Smuts H, Kolia F, Van Rensburg EJ.
    Haemophilia; 2000 Mar; 6(2):93-7. PubMed ID: 10781195
    [Abstract] [Full Text] [Related]

  • 7. [Parvovirus B19 infection in patients with congenital blood coagulation disorders].
    Aguilar Franco C, Lucía Cuesta JF, Ferrer Torres J, Omeñaca Teres M.
    Med Clin (Barc); 1997 May 03; 108(17):641-6. PubMed ID: 9312580
    [Abstract] [Full Text] [Related]

  • 8. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP.
    Transfusion; 2006 Sep 03; 46(9):1593-600. PubMed ID: 16965589
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A, Monzini M, Tagariello G, Scaraggi FA, Mannucci PM, Emoclot15 Study Members.
    Haemophilia; 2006 Mar 03; 12(2):128-32. PubMed ID: 16476086
    [Abstract] [Full Text] [Related]

  • 10. Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: a report from a single Spanish institution.
    Canales MA, Pinilla J, Mateos P, Martínez Zapico R, Alvarez T, Jiménez VM, Quintana M, Villar A, Hernández Navarro F, Magallón M.
    Vox Sang; 1998 Mar 03; 74(4):260-1. PubMed ID: 9691409
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.
    Geng Y, Wu CG, Bhattacharyya SP, Tan D, Guo ZP, Yu MY.
    Transfusion; 2007 May 03; 47(5):883-9. PubMed ID: 17465954
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
    Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R, Santoro R, Schiavoni M.
    Transfusion; 1997 May 03; 37(5):517-22. PubMed ID: 9149778
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product.
    Yee TT, Williams MD, Hill FG, Lee CA, Pasi KJ.
    Thromb Haemost; 1997 Sep 03; 78(3):1027-9. PubMed ID: 9308748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
    Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F.
    AIDS; 1992 Jul 03; 6(7):679-84. PubMed ID: 1503687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.